Brief: Neumora Therapeutics Inc On May 14, Receives Nasdaq Non-Compliance Notice
May 16 (Reuters) - Neumora Therapeutics Inc NMRA.O: NEUMORA THERAPEUTICS INC -ON MAY14, RECEIVES NASDAQ NON-COMPLIANCE NOTICE - SEC FILING Further company coverage: NMRA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neumora Therapeutics
See all newsNeumora Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Neumora Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update
Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Neumora Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex